Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of ISIS 301012 (Mipomersen) in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy

This study has been completed.
Sponsor:
Collaborator:
Ionis Pharmaceuticals, Inc.
Information provided by:
Kastle Therapeutics, LLC
ClinicalTrials.gov Identifier:
NCT00281008
First received: January 20, 2006
Last updated: August 1, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2007
  Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)